Published December 1990
| Version v1
Journal article
Phosphorus-32-colloidal chromic phosphate: Treatment of choice for malignant pericardial effusion
Creators
- 1. Kaiser Foundation Hospital, West Los Angeles, CA (USA)
Description
A 68-yr-old male with agnogenic myeloid metaplasia was given phosphorus-32-colloidal chromic phosphate intrapericardially for the treatment of malignant pericardial effusion. Technetium-99m-sulfur colloid was used to verify catheter placement and to visualize distribution within the pericardium. Estimated dosimetry for this mode of therapy is presented, and it is suggested that pericardial administration of phosphorus-32-colloidal chromic phosphate is the treatment of choice for malignant pericardial effusion
Additional details
Publishing Information
- Journal Title
- Journal of Nuclear Medicine
- Journal Volume
- 31
- Journal Issue
- 12
- Series
- J. Nucl. Med.
- Journal Page Range
- 2034-2036
- ISSN
- 0161-5505
- CODEN
- JNMEA
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 22034388
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- COLLOIDS; DOSIMETRY; ISOMERIC NUCLEI; NEOPLASMS; PATIENTS; PERICARDIUM; PHOSPHATES; PHOSPHORUS 32; RADIOTHERAPY; TECHNETIUM 99; TISSUE DISTRIBUTION
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BODY; CARDIOVASCULAR SYSTEM; DAYS LIVING RADIOISOTOPES; DISEASES; DISPERSIONS; DISTRIBUTION; HEART; HOURS LIVING RADIOISOTOPES; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTO; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LIGHT NUCLEI; MEDICINE; MEMBRANES; NUCLEI; ODD-EVEN NUCLEI; ODD-ODD NUCLEI; ORGANS; OXYGEN COMPOUNDS; PHOSPHORUS COMPOUNDS; PHOSPHORUS ISOTOPES; RADIOISOTOPES; SEROUS MEMBRANES; TECHNETIUM ISOTOPES; THERAPY; YEARS LIVING RADIOISOTOPES